MEDIUM confidence: 100% data completeness, but the composite (52) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Avg target $74 (last qtr, 10 analysts) → $77 (last mo, 5) (+2.9%).
Buy-rated share 83% → 83% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $0.60 | $0.68 | +13.3% |
| Apr 2026 | $0.47 | $0.57 | +22.2% |
| Jan 2026 | $0.29 | $0.47 | +64.8% |
| Oct 2025 | $0.42 | $0.50 | +18.7% |
| Jul 2025 | $0.45 | $0.54 | +20.1% |
| Apr 2025 | $0.24 | $0.24 | +1.0% |
| Jan 2025 | $0.36 | $0.31 | -13.9% |
| Oct 2024 | $0.36 | $0.38 | +6.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $22.4B— | $23.3B+4.4% | $22.7B-2.7% | $25.5B+12.1% | $25.7B+1.1% |
| EPS (dil.) | $2.90— | $2.39-17.6% | $1.28-46.4% | $1.30+1.6% | $1.52+16.9% |
| Free Cash Flow | $5.6B— | $1.7B-70.2% | $455M-72.8% | $2.4B+416.9% | $1.1B-52.6% |
| Gross Margin | 37.1% | 34.7%-2.4pp | 30.3%-4.4pp | 29.5%-0.8pp | 27.0%-2.5pp |
| Operating Margin | 34.9% | 32.4%-2.6pp | 26.8%-5.6pp | 27.0%+0.2pp | 24.4%-2.5pp |
| Net Margin | 19.2% | 14.8%-4.4pp | 8.1%-6.7pp | 7.4%-0.7pp | 8.6%+1.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net insider -$4.4M over 180 days (0 open-market buys, 5 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 9.0%/yr (revenue basis).
Base free cash flow $1.3B (avg FY2023–FY2025; latest year $1.1B) · equity value $98.1B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 52 for FCX indicates a neutral outlook, driven by strong momentum with a 12-month return of 61.5% and a bullish 50-day versus 200-day moving average trend. However, this is offset by lower scores in value, where the stock trades at a P/E of 33.6, and growth, which is hindered by a decline in free cash flow growth of 52.6%. The long-term and short-term scores are relatively aligned, with only a 5-point difference, suggesting a consistent view across different time horizons. FCX's profitability scores are moderate, with an ROE of 15.3% and operating margin of 26.7%.